Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD
Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD have?
Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD published?
Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD has 2024 year in the ScholarIQ index.
What is the open-access status of Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD?
Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD has green oa status in the ScholarIQ index.
What is the DOI of Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD?
The DOI for Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD is on the source record.
What is the PMID of Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD?
The PMID for Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD is on the source record.
What is the OpenAlex record for Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD?
The OpenAlex for Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD is on the source record.